Mi SciELO
Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Anales del Sistema Sanitario de Navarra
versión impresa ISSN 1137-6627
Resumen
FERNANDEZ-CALDERON, M. y BETES IBANEZ, M.T.. Aspirin in the primary prevention of colorectal cancer. Anales Sis San Navarra [online]. 2012, vol.35, n.2, pp.261-267. ISSN 1137-6627. https://dx.doi.org/10.4321/S1137-66272012000200008.
Aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) have been associated with a reduction in the risk of developing adenomas and colorectal cancer. The available scientific evidence justifies the need for more studies that evaluate the protective effect of aspirin and other NSAIDs as a preventive measure against cancer of the colon; define the minimum efficient dosage; the age at which to begin treatment; the most convenient duration of the latter; and the sub-populations for which the benefits of chemoprophylaxis outweigh possible adverse effects.
Palabras clave : Aspirin; Colorectal cancer; Prevention.